Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

PC09.05 Debate 2: Large Cell Neuroendocrine Carcinoma Should Be Treated Like NSCLC or SCLC? - SCLC

Journal of Thoracic Oncology

English

P195 Outcomes in Emergency Admissions With Lung Cancer: A 1-Year Perspective From a Teaching Hospital

English

P1.06-046 Can We Better Manage Advanced NSCLC in the Elderly With the New Therapeutic Agents? Preliminary Analysis of a Real-Life Multicenter Study

Journal of Thoracic Oncology

English

P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.13-28 Comparison of ddPCR and NGS in Liquid Biopsy to Pathology Results in EGFR-Mutated NSCLC

Journal of Thoracic Oncology

English

Targeted Therapy for Patients With BRAF-Mutant Lung Cancer Results From the European EURAF Cohort

Journal of Thoracic Oncology

English

Icotinib in Patients With Pretreated Advanced Esophageal Squamous Cell Carcinoma With EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study

Journal of Thoracic Oncology

English

P2.06-14 Does Size Matter? A Population-Based Analysis of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology

English

P1.05-14 Autofluorescence Mode of Thoracoscope Improves Visceral Pleural Invasion Diagnosis in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Genetic Variants and Risk of Lung Cancer in Never Smokers

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

PC09.05 Debate 2: Large Cell Neuroendocrine Carcinoma Should Be Treated Like NSCLC or SCLC? - SCLC

P195 Outcomes in Emergency Admissions With Lung Cancer: A 1-Year Perspective From a Teaching Hospital

P1.06-046 Can We Better Manage Advanced NSCLC in the Elderly With the New Therapeutic Agents? Preliminary Analysis of a Real-Life Multicenter Study

P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

P2.13-28 Comparison of ddPCR and NGS in Liquid Biopsy to Pathology Results in EGFR-Mutated NSCLC

Targeted Therapy for Patients With BRAF-Mutant Lung Cancer Results From the European EURAF Cohort

Icotinib in Patients With Pretreated Advanced Esophageal Squamous Cell Carcinoma With EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study

P2.06-14 Does Size Matter? A Population-Based Analysis of Malignant Pleural Mesothelioma

P1.05-14 Autofluorescence Mode of Thoracoscope Improves Visceral Pleural Invasion Diagnosis in Non-Small Cell Lung Cancer

Genetic Variants and Risk of Lung Cancer in Never Smokers